International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

Eligibility: All College of Pharmacy Students Mission: The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a global organization dedicated to advancing the science and practice of health economics and outcomes research (HEOR) to improve decision-making in healthcare. The University of Rhode Island ISPOR Student Chapter serves as a platform for students interested in HEOR […]

Continue reading "International Society for Pharmacoeconomics and Outcomes Research (ISPOR)"

Dr. Erica Estus Receives Two National Awards from ASCP

Clinical Professor Erica Estus, PharmD, BCGP, FASCP has been nationally recognized for her outstanding contributions to pharmacy education and senior care. At the American Society of Consultant Pharmacists (ASCP) 2025 Annual Meeting & Exhibition in San Diego, she received not one but two of the organization’s top honors: the ASCP Outstanding Faculty Award and the […]

Continue reading "Dr. Erica Estus Receives Two National Awards from ASCP"

How URI Prepared Dr. Steve Shen, PhD ’17, for a Career in Biomedical and Pharmaceutical Sciences

Dr. Yuanjun “Steve” Shen, PhD ’17, is a proud graduate of the University of Rhode Island College of Pharmacy’s Pharmaceutical Science program and now serves as an Assistant Professor of Pharmaceutical Sciences at Binghamton University. While at URI, Dr. Shen trained under world-class faculty, gained hands-on research experience, and built the foundation for a career […]

Continue reading "How URI Prepared Dr. Steve Shen, PhD ’17, for a Career in Biomedical and Pharmaceutical Sciences"

URI to MIT. Cancer Research to CEO: A Q&A with Kevin Bian, PhD ’19

URI roots, MIT breakthroughs, and a CEO leading the charge against cancer—Kevin Bian’s journey shows where curiosity and resilience can take you From the lab bench at URI to the cutting-edge of cancer research at MIT, Kevin Bian’s journey is fueled by curiosity, resilience, and a commitment to making science matter. As a postdoctoral researcher […]

Continue reading "URI to MIT. Cancer Research to CEO: A Q&A with Kevin Bian, PhD ’19"